DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Medical Use of Marijuana
August 2, 2017

Medical marijuana may be used for patient care if it is prescribed by a qualified Florida licensed physician in a manner that is consistent with the standard of care. Continue reading


Third Quarterly Performance Report (QPR) Released
August 2, 2017

The QPR contains revenue, expenditure and performance measure information from the Department of Health. Continue reading